Litigation
Louisiana Health Service & Indemnity Co. v. Celgene Corp.
pending/consolidated- Court
- S.D.N.Y.
- Filed
- 2023-09-05
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Antitrust action in which the '428 patent is cited as part of the challenged Celgene patent portfolio; Blue Cross LA sued Celgene in S.D.N.Y. Status is generally pending/consolidated.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
In the news
What the press has reported about this case, summarized with links to the source articles.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).